Chromium deficiency and cardiovascular risk.

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Nutritional Science

Background:

• Plasma chromium levels are significantly lower in patients with coronary artery disease (CAD) compared to healthy individuals.
• Chromium, also known as glucose tolerance factor (GTF), plays a role in physiological functions linked to cardiovascular risk factors.
• Existing literature suggests chromium's involvement in managing insulin levels and activities.

Purpose of the Study:

• To investigate the potential link between chromium deficiency and coronary artery disease.
• To explore the role of chromium in lipid and glucide metabolism concerning cardiovascular health.
• To determine if chromium deficiency could be a primary risk factor for cardiovascular disease.

Main Methods:

• Review of existing literature on chromium's physiological functions and cardiovascular risk factors.
• Analysis of recent measurements comparing plasma chromium levels in CAD patients and normal subjects.
• Correlation analysis between chromium levels, insulin activity, and metabolic parameters.

Main Results:

• Patients with coronary artery disease exhibit markedly lower plasma chromium levels than normal subjects.
• Chromium deficiency is associated with impaired lipid and glucide metabolism.
• Chromium deficiency leads to elevated circulating insulin levels.

Conclusions:

• Chromium deficiency may represent a primary risk factor for cardiovascular disease.
• The observed effects on metabolism and insulin levels suggest a significant role for chromium in cardiovascular health.
• Further research is warranted to elucidate the direct causal relationship and therapeutic implications.